Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Safety and Efficacy Study of PTC124 in Duchenne Muscular Dystrophy

This study has been completed.
Sponsor:
Collaborator:
Muscular Dystrophy Association
Information provided by:
PTC Therapeutics
ClinicalTrials.gov Identifier:
NCT00264888
First received: December 9, 2005
Last updated: January 9, 2009
Last verified: January 2009
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2007
  Primary Completion Date: May 2007 (Final data collection date for primary outcome measure)
No publications provided by PTC Therapeutics

Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):